Having shown that AD contains similar high numbers of IL26+ TH17 intermediates but lower expression levels of epidermal TGF-β1 and reduced numbers of IL17A+ cells when compared to psoriasis, we sought to compare the location of IL-26 expression in both diseases using spatial transcriptomics. The gene discussed is IL17A; the disease is Alzheimer disease.